Alliance Global Partners Initiates Coverage On RenovoRx with Buy Rating, Announces Price Target of $4
Portfolio Pulse from Benzinga Newsdesk
Alliance Global Partners analyst Scott Henry initiated coverage on RenovoRx (NASDAQ:RNXT) with a Buy rating and set a price target of $4.
February 02, 2024 | 1:04 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RenovoRx was initiated with a Buy rating and a price target of $4 by Alliance Global Partners.
The initiation of coverage by a reputable analyst with a Buy rating and a specific price target usually signals a positive outlook on the stock, potentially leading to increased investor interest and a positive short term price movement.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100